Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood-based immune-endocrine biomarkers of treatment response in depression
Man K. Chan, Jason D. Cooper, Mariska Bot, et al.
Journal of Psychiatric Research (2016) Vol. 83, pp. 249-259
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence
Douglas E. Vaughan, Rahul Rai, Sadiya S. Khan, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2017) Vol. 37, Iss. 8, pp. 1446-1452
Open Access | Times Cited: 197
The potential of predictive analytics to provide clinical decision support in depression treatment planning
Ronald C. Kessler
Current Opinion in Psychiatry (2017) Vol. 31, Iss. 1, pp. 32-39
Closed Access | Times Cited: 91
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 85
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC–MS/MS and bioinformatics analysis
Juanjuan Ren, Guoqing Zhao, Xiujia Sun, et al.
Psychoneuroendocrinology (2017) Vol. 86, pp. 17-24
Closed Access | Times Cited: 59
The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review
Carlos Fernández-Pereira, Roberto Carlos Agís‐Balboa
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2561-2561
Open Access
Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson’s disease
Carolyn Reuland, Frank Church
Medical Hypotheses (2020) Vol. 138, pp. 109602-109602
Open Access | Times Cited: 30
Accelerated epigenetic aging and decreased natural killer cells based on DNA methylation in patients with untreated major depressive disorder
Ryota Shindo, Takaki Tanifuji, Kenji Okazaki, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Elevated levels of apolipoprotein A4 in umbilical cord serum from the maternal major depressive disorder
Seiko Matsuo, Yoshinori Moriyama, Takafumi Ushida, et al.
Journal of Obstetrics and Gynaecology Research (2024)
Open Access | Times Cited: 3
Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
Indira Mendez‐David, Céline Boursier, Valérie Domergue, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 31
Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression
Huai Tao, Xia Chen, Hongfei Zhou, et al.
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 24
Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?
Silvia Hoirisch-Clapauch
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 525-533
Closed Access | Times Cited: 23
An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks
Eun Young Kim, Hee‐Sung Ahn, Min Young Lee, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 455-455
Open Access | Times Cited: 19
Prognostic Significance of Blood-Based Baseline Biomarkers in Treatment-Resistant Depression: A Literature Review of Available Studies on Treatment Response
Theano Gkesoglou, Stavroula I. Bargiota, Eleni Iordanidou, et al.
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 11
Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression
Seung‐Hoon Lee, Cheolmin Shin, Young‐Hoon Ko, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 1, pp. 147-161
Open Access | Times Cited: 6
Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters
Maria Skibińska, Paweł Kapelski, Aleksandra Rajewska‐Rager, et al.
Nordic Journal of Psychiatry (2017) Vol. 72, Iss. 3, pp. 191-196
Closed Access | Times Cited: 16
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response
Christoph W. Turck, Paul C. Guest, Giuseppina Maccarrone, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 14
A Machine Learning‐Based Approach for the Prediction of Anticoagulant Activity of Hypericum perforatum L. and Evaluation of Compound Activity
Zhiyong Zhang, Wennan Nie, Yijing Zhang, et al.
Phytochemical Analysis (2024)
Open Access | Times Cited: 1
Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression
Lívia Ramos-da-Silva, Pamela T. Carlson, Lícia C. Silva-Costa, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 3-4, pp. 49-59
Open Access | Times Cited: 10
Predictive protein markers for depression severity in mood disorders: A preliminary trans-diagnostic approach study
Hyunju Lee, Sang Jin Rhee, Jayoun Kim, et al.
Journal of Psychiatric Research (2021) Vol. 142, pp. 63-72
Closed Access | Times Cited: 10
Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
Hye In Woo, Jisook Park, Shinn‐Won Lim, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104
Qi Guo, Yan Jun, Yi Lin Shen, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 10, pp. 2060-2070
Closed Access | Times Cited: 5
Molecular biomarkers in depression: Toward personalized psychiatric treatment
Anand Gururajan, John F. Cryan, Timothy G. Dinan
Elsevier eBooks (2019), pp. 319-338
Closed Access | Times Cited: 4
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
Adam J. Walker, Mohammadreza Mohebbi, Michaël Maes, et al.
Brain Behavior & Immunity - Health (2022) Vol. 27, pp. 100581-100581
Open Access | Times Cited: 3
Common protein networks for various drug regimens of major depression are associated with complement and immunity
Seungyeon Lee, Sora Mun, Jiyeong Lee, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 9, pp. 798-806
Closed Access
Page 1 - Next Page

Scroll to top